Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Fallopian Tube Neoplasms"" wg kryterium: Temat


Tytuł :
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study.
Autorzy :
Van Calster B; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands.; EPI-Centre, KU Leuven, Leuven, Belgium.
Valentin L; Department of Obstetrics and Gynaecology, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Froyman W; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium.; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.
Landolfo C; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium.; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK.
Ceusters J; Laboratory of Tumour Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.
Testa AC; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.; Department of Life Science and Public Health, Universita' Cattolica del Sacro Cuore, Rome, Italy.
Wynants L; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium.; Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands.
Sladkevicius P; Department of Obstetrics and Gynaecology, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Van Holsbeke C; Department of Obstetrics and Gynaecology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Domali E; First Department of Obstetrics and Gynaecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Fruscio R; Clinic of Obstetrics and Gynaecology, University of Milan-Bicocca, San Gerardo Hospital, Monza, Italy.
Epstein E; Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.; Department of Obstetrics and Gynaecology, Södersjukhuset, Stockholm, Sweden.
Franchi D; Preventive Gynaecology Unit, Division of Gynaecology, European Institute of Oncology IRCCS, Milan, Italy.
Kudla MJ; Department of Perinatology and Oncological Gynaecology, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Chiappa V; Department of Gynaecologic Oncology, National Cancer Institute of Milan, Milan, Italy.
Alcazar JL; Department of Obstetrics and Gynaecology, Clinica Universidad de Navarra, School of Medicine, Pamplona, Spain.
Leone FPG; Department of Obstetrics and Gynaecology, Biomedical and Clinical Sciences Institute L. Sacco, University of Milan, Milan, Italy.
Buonomo F; Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.
Coccia ME; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Guerriero S; Department of Obstetrics and Gynaecology, University of Cagliari, Policlinico Universitario Duilio Casula, Monserrato, Cagliari, Italy.
Deo N; Department of Obstetrics and Gynaecology, Whipps Cross Hospital, London, UK.
Jokubkiene L; Department of Obstetrics and Gynaecology, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Savelli L; Department of Obstetrics and Gynaecology, University of Bologna, Bologna, Italy.
Fischerová D; Gynaecological Oncology Centre, Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Czekierdowski A; First Department of Gynaecological Oncology and Gynaecology, Medical University of Lublin, Lublin, Poland.
Kaijser J; Department of Obstetrics and Gynaecology, Ikazia Hospital, Rotterdam, Netherlands.
Coosemans A; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.; Laboratory of Tumour Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Scambia G; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.; Department of Life Science and Public Health, Universita' Cattolica del Sacro Cuore, Rome, Italy.
Vergote I; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.; Laboratory of Tumour Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Bourne T; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium.; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK.
Timmerman D; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium .; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2020 Jul 30; Vol. 370, pp. m2614. Date of Electronic Publication: 2020 Jul 30.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Validation Study
Journal Info :
Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Logistic Models*
Fallopian Tube Neoplasms/*diagnosis
Fallopian Tube Neoplasms/*pathology
Ovarian Neoplasms/*diagnosis
Ovarian Neoplasms/*pathology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; CA-125 Antigen/blood ; Calibration ; Conservative Treatment ; Fallopian Tube Neoplasms/therapy ; Female ; Humans ; Membrane Proteins/blood ; Middle Aged ; Ovarian Neoplasms/therapy ; Ovariectomy ; Prospective Studies ; Risk Assessment/methods ; Ultrasonography ; Young Adult
Czasopismo naukowe
Tytuł :
Primary transitional cell carcinoma of the fallopian tube: A case report and literature review.
Autorzy :
Lee DH; Department of Obstetrics and Gynecology, Jeonbuk National University Hospital-Jeonbuk National University Medical School.; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.
Cho DH; Department of Obstetrics and Gynecology, Jeonbuk National University Hospital-Jeonbuk National University Medical School.; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.
Kim KM; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.; Department of Pathology.
Yim CY; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.; Division of Hematology and oncology, Department of Internal Medicine, Jeonbuk National University Hospital-Jeonbuk National University Medical School, Jeonju, Republic of Korea.
Lee NR; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.; Division of Hematology and oncology, Department of Internal Medicine, Jeonbuk National University Hospital-Jeonbuk National University Medical School, Jeonju, Republic of Korea.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 May 29; Vol. 99 (22), pp. e20499.
Typ publikacji :
Case Reports; Journal Article; Review
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Carcinoma, Transitional Cell/*diagnostic imaging
Carcinoma, Transitional Cell/*surgery
Fallopian Tube Neoplasms/*diagnostic imaging
Fallopian Tube Neoplasms/*surgery
Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinoma, Transitional Cell/pathology ; Cisplatin/therapeutic use ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Hysterectomy ; Magnetic Resonance Imaging ; Neoplasm Recurrence, Local/drug therapy ; Palliative Care ; Salpingo-oophorectomy
Czasopismo naukowe
Tytuł :
Outcomes in Advanced Stage Epithelial Ovarian, Fallopian Tubal, and Peritoneal Cancer after Primary Surgery and Adjuvant Chemotherapies: A Single-Institute Real-World Experience.
Autorzy :
Chang CH; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Kuo HL; Department of Nursing, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Chen TC; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Weng CS; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Lim L; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Huang WC; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Chang CL; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Su TH; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Hsinchu Branch, Hsinchu 30071, Taiwan.
Wang KG; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Wang KL; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taitung Branch, Taitung 95054, Taiwan.; Department of General Education, MacKay Junior College of Medicine, Nursing and Management, New Taipei City 11260, Taiwan.
Yang YC; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Chen JR; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.; Department of General Education, MacKay Junior College of Medicine, Nursing and Management, New Taipei City 11260, Taiwan.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2020 May 18; Vol. 17 (10). Date of Electronic Publication: 2020 May 18.
Typ publikacji :
Journal Article
Journal Info :
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE
MeSH Terms :
Chemotherapy, Adjuvant*
Fallopian Tube Neoplasms*/drug therapy
Fallopian Tube Neoplasms*/surgery
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/surgery
Peritoneal Neoplasms*/drug therapy
Peritoneal Neoplasms*/surgery
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Incidental occurrence of high grade serous tubal adenocarcinoma after prophylactic adnexectomy in benign gynecological surgery.
Transliterated Title :
Náhodný výskyt high grade serózneho adenokarcinómu tuby v rámci profylaktickej adnexektómie pri benígnej gynekologickej operácii.
Autorzy :
Kozolková D
Spodniaková B
Hajduková M
Hollý I
Záhumenský J
Pokaż więcej
Źródło :
Ceska gynekologie [Ceska Gynekol] 2020 Winter; Vol. 85 (2), pp. 111-115.
Typ publikacji :
Case Reports; Journal Article
Journal Info :
Publisher: Ceská lékarska spolecnost J. E. Purkyne Country of Publication: Czech Republic NLM ID: 9423768 Publication Model: Print Cited Medium: Print ISSN: 1210-7832 (Print) Linking ISSN: 12107832 NLM ISO Abbreviation: Ceska Gynekol Subsets: MEDLINE
MeSH Terms :
Prophylactic Surgical Procedures*
Adenocarcinoma/*surgery
Adnexal Diseases/*surgery
Fallopian Tube Neoplasms/*surgery
Gynecologic Surgical Procedures/*methods
Adenocarcinoma/pathology ; Adnexal Diseases/pathology ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Hysterectomy, Vaginal ; Incidental Findings ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/surgery ; Salpingectomy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations.
Autorzy :
McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland.
Apellaniz-Ruiz M; Department of Human Genetics, McGill University.; Cancer Axis, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada.
Chong AL; Department of Human Genetics, McGill University.; Cancer Axis, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada.
Hanley KZ; Department of Pathology, and Laboratory Medicine, Emory University Hospital.
Velázquez Vega JE; Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta and Emory University, Atlanta, GA.
McVeigh TP; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Foulkes WD; Department of Human Genetics, McGill University.; Cancer Axis, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada.
Pokaż więcej
Źródło :
The American journal of surgical pathology [Am J Surg Pathol] 2020 Jun; Vol. 44 (6), pp. 738-747.
Typ publikacji :
Case Reports; Journal Article
Journal Info :
Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7707904 Publication Model: Print Cited Medium: Internet ISSN: 1532-0979 (Electronic) Linking ISSN: 01475185 NLM ISO Abbreviation: Am J Surg Pathol Subsets: MEDLINE
MeSH Terms :
DEAD-box RNA Helicases/*genetics
Fallopian Tube Neoplasms/*genetics
Neoplastic Syndromes, Hereditary/*genetics
Ovarian Neoplasms/*genetics
Rhabdomyosarcoma, Embryonal/*genetics
Ribonuclease III/*genetics
Adolescent ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Middle Aged ; Mutation ; Ovarian Neoplasms/pathology ; Rhabdomyosarcoma, Embryonal/pathology
Czasopismo naukowe
Tytuł :
Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal versus Dose-Dense Platinum/Paclitaxel Chemotherapy without Bevacizumab.
Autorzy :
Ting WH; Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.
Hsiao CH; Division of Medical Oncology and Hematology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.
Chen HH; Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.
Wei MC; Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.
Lin HH; Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.; Department of Obstetrics and Gynecology, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei 100225, Taiwan.
Hsiao SM; Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.; Department of Obstetrics and Gynecology, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei 100225, Taiwan.; Graduate School of Biotechnology and Bioengineering, Yuan Ze University, Taoyuan 320315, Taiwan.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2020 May 20; Vol. 17 (10). Date of Electronic Publication: 2020 May 20.
Typ publikacji :
Journal Article
Journal Info :
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Fallopian Tube Neoplasms*/drug therapy
Ovarian Neoplasms*/drug therapy
Bevacizumab/administration & dosage ; Carboplatin ; Disease-Free Survival ; Female ; Humans ; Infusions, Parenteral ; Middle Aged ; Paclitaxel/administration & dosage ; Platinum/administration & dosage
Czasopismo naukowe
Tytuł :
Anterior mediastinal metastasis of primary fallopian tube adenocarcinoma: a case report.
Autorzy :
Zhang B; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.
Liu R; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.; Department of Lung Cancer Surgery; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Li T; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.
Chen F; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.
Huo H; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.
Ren D; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.; Department of Lung Cancer Surgery; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Ren F; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.; Department of Lung Cancer Surgery; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Xu S; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.; Department of Lung Cancer Surgery; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Xu X; Colleges of Nursing, Tianjin Medical University, Qixiangtai Road No.22, Tianjin, 300070, China. .
Song Z; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China. .; Department of Lung Cancer Surgery; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China. .
Pokaż więcej
Źródło :
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2020 May 11; Vol. 15 (1), pp. 77. Date of Electronic Publication: 2020 May 11.
Typ publikacji :
Case Reports; Journal Article
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 101265113 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-8090 (Electronic) Linking ISSN: 17498090 NLM ISO Abbreviation: J Cardiothorac Surg Subsets: MEDLINE
MeSH Terms :
Adenocarcinoma/*pathology
Fallopian Tube Neoplasms/*pathology
Mediastinal Neoplasms/*secondary
Mediastinum/*pathology
Neoplasm Recurrence, Local/*surgery
Adenocarcinoma/surgery ; Aged ; Fallopian Tube Neoplasms/surgery ; Fallopian Tubes ; Female ; Humans ; Incidence ; Mediastinal Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Autorzy :
Pfisterer J; Gynaecologic Oncology Center, Kiel, Germany. Electronic address: .
Shannon CM; Oncology Department, Mater Cancer Care Centre, Brisbane, QLD, Australia.
Baumann K; Gynaecology Department, Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany.
Rau J; Coordinating Center for Clinical Trials, Philipps-University, Marburg, Germany.
Harter P; Department of Gynecology and Gynecological Oncology, Kliniken Essen-Mitte, Essen, Germany.
Joly F; Gynaecology Department, Centre François Baclesse, Caen, France.
Sehouli J; Department of Gynaecology, and European Competence Center for Ovarian Cancer, Charité - Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany.
Canzler U; Department of Gynaecology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Schmalfeldt B; Technical University of Munich-Klinikum Rechts der Isar, Germany; Department of Gynaecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Dean AP; Gynaecological Oncology Department, St John of God Hospital, Subiaco, WA, Australia.
Hein A; Gynaecology Department, Erlangen University Hospital, Erlangen, Germany.
Zeimet AG; Department of Obstetrics and Gynaecology, Innsbruck Medical University, Innsbruck, Austria.
Hanker LC; Gynaecology Department, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Petit T; Paul Strauss Cancer Center and Gynaecology Department, University of Strasbourg, Strasbourg, France.
Marmé F; Gynaecology Department, National Center for Tumor Disease, University of Heidelberg, Heidelberg, Germany; Department of Gynaecology and Obstetrics, University Hospital Mannheim, Mannheim, Germany.
El-Balat A; Department of Gynaecology and Obstetrics, University of Frankfurt/Main, Frankfurt, Germany.
Glasspool R; National Cancer Research Institute, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK.
de Gregorio N; Department of Obstetrics and Gynaecology, University of Ulm, Ulm, Germany.
Mahner S; Department of Gynaecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilian-University, Munich, Germany.
Meniawy TM; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Park-Simon TW; Department of Gynaecology and Obstetrics, Medical University Hannover, Hannover, Germany.
Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
Costan C; Department of Oncology, Hôpital Michallon, Grenoble, France.
Meier W; Department of Gynaecology and Obstetrics, Evangelisches Krankenhaus Düsseldorf, Germany; Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.
Reinthaller A; Department of Gynecology and Gynecologic Oncology, Comprehensive Cancer Centre, University Hospital for Gynaecology, Medical University Vienna, Vienna, Austria.
Goh JC; Royal Brisbane & Women's Hospital, Brisbane, QLD, Australia.
L'Haridon T; Centre Hospitalier Départemental les Oudairies, La Roche-Sur-Yon, France.
Baron Hay S; Women's Health, Royal North Shore Hospital, Sydney, NSW, Australia.
Kommoss S; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
du Bois A; Department of Gynecology and Gynecological Oncology, Kliniken Essen-Mitte, Essen, Germany.
Kurtz JE; Haematology-Oncology Department, Centre Hospitalier Régional et Universitaire de Strasbourg Hôpital Civil, Strasbourg, France.
Pokaż więcej
Corporate Authors :
AGO-OVAR 2.21/ENGOT-ov 18 Investigators
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 May; Vol. 21 (5), pp. 699-709. Date of Electronic Publication: 2020 Apr 16.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol. Subsets: MEDLINE
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Bevacizumab/*administration & dosage
Fallopian Tube Neoplasms/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Ovarian Neoplasms/*drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Australia/epidemiology ; Austria/epidemiology ; Bevacizumab/adverse effects ; Carboplatin/administration & dosage ; Carboplatin/adverse effects ; Doxorubicin/administration & dosage ; Doxorubicin/analogs & derivatives ; Fallopian Tube Neoplasms/pathology ; Female ; France/epidemiology ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Ovarian Neoplasms/pathology ; Paclitaxel/administration & dosage ; Paclitaxel/adverse effects ; Platinum/administration & dosage ; Platinum/adverse effects ; Polyethylene Glycols/administration & dosage
Czasopismo naukowe
Tytuł :
Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study.
Autorzy :
Shibutani T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Nagao S; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan. .
Suzuki K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Kaneda M; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Yamamoto K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Jimi T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Yano H; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Kitai M; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Shiozaki T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Matsuoka K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Sudo T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Yamaguchi S; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2020 Mar; Vol. 25 (3), pp. 502-507. Date of Electronic Publication: 2019 Nov 01.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int. J. Clin. Oncol. Subsets: MEDLINE
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Carcinoma, Ovarian Epithelial/*drug therapy
Fallopian Tube Neoplasms/*drug therapy
Peritoneal Neoplasms/*drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/administration & dosage ; Carcinoma, Ovarian Epithelial/mortality ; Carcinoma, Ovarian Epithelial/surgery ; Cytoreduction Surgical Procedures ; Fallopian Tube Neoplasms/mortality ; Fallopian Tube Neoplasms/surgery ; Female ; Humans ; Middle Aged ; Multivariate Analysis ; Neoadjuvant Therapy ; Paclitaxel/administration & dosage ; Peritoneal Neoplasms/mortality ; Peritoneal Neoplasms/surgery ; Progression-Free Survival ; Proportional Hazards Models ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Prognostic value of serum HE4 in patients with advanced ovarian, fallopian tube, and peritoneal carcinoma.
Autorzy :
Mi D; Department of Clinical Laboratory, Tianjin Central Hospital of Obstetrics and Gynecology, No. 156, Nankai Three Road, Tianjin, China. .
Zhang Y; Department of Clinical Laboratory, Tianjin Central Hospital of Obstetrics and Gynecology, No. 156, Nankai Three Road, Tianjin, China.
Pokaż więcej
Źródło :
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2020 Mar; Vol. 301 (3), pp. 779-785. Date of Electronic Publication: 2020 Feb 08.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8710213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0711 (Electronic) Linking ISSN: 09320067 NLM ISO Abbreviation: Arch. Gynecol. Obstet. Subsets: MEDLINE
MeSH Terms :
Biomarkers, Tumor/*blood
Fallopian Tube Neoplasms/*blood
Ovarian Neoplasms/*blood
Peritoneal Neoplasms/*blood
WAP Four-Disulfide Core Domain Protein 2/*genetics
Adult ; Aged ; Fallopian Tube Neoplasms/mortality ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Middle Aged ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/pathology ; Peritoneal Neoplasms/mortality ; Peritoneal Neoplasms/pathology ; Prognosis ; Survival Analysis
Czasopismo naukowe
Tytuł :
Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
Autorzy :
McCool KW; Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan.
Freeman ZT; Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Zhai Y; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Wu R; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Hu K; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan.
Liu CJ; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Tomlins SA; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Fearon ER; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.; Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan.; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Magnuson B; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.
Kuick R; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.
Cho KR; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan .; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2020 Feb 15; Vol. 80 (4), pp. 877-889. Date of Electronic Publication: 2019 Dec 05.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
Journal Info :
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res. Subsets: MEDLINE
MeSH Terms :
Cystadenocarcinoma, Serous/*genetics
Fallopian Tube Neoplasms/*genetics
Neurofibromin 1/*genetics
Ovarian Neoplasms/*genetics
Tumor Microenvironment/*immunology
Animals ; Carcinoma, Endometrioid/genetics ; Carcinoma, Endometrioid/immunology ; Carcinoma, Endometrioid/pathology ; Cystadenocarcinoma, Serous/immunology ; Cystadenocarcinoma, Serous/pathology ; Disease Models, Animal ; Fallopian Tube Neoplasms/immunology ; Fallopian Tube Neoplasms/pathology ; Fallopian Tubes/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Mice ; Mice, Transgenic ; Myeloid-Derived Suppressor Cells/immunology ; Ovarian Neoplasms/immunology ; RNA-Seq ; T-Lymphocytes, Regulatory/immunology
Czasopismo naukowe
Tytuł :
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells.
Autorzy :
Hu Z; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
Artibani M; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Gene Regulatory Networks in Development and Disease Laboratory, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.
Alsaadi A; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
Wietek N; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.
Morotti M; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.
Shi T; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
Zhong Z; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
Santana Gonzalez L; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
El-Sahhar S; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
KaramiNejadRanjbar M; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
Mallett G; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
Feng Y; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.
Masuda K; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
Zheng Y; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
Chong K; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.
Damato S; Department of Histopathology, Oxford University Hospitals, Oxford OX3 9DU, UK.
Dhar S; Department of Histopathology, Oxford University Hospitals, Oxford OX3 9DU, UK.
Campo L; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.
Garruto Campanile R; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.
Soleymani Majd H; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.
Rai V; Department of Gynaecology, Oxford University Hospitals NHS Trust, Oxford OX3 9DU, UK.
Maldonado-Perez D; Oxford Radcliffe Biobank, Nuffield Department of Surgical Sciences, University of Oxford, Oxford OX3 9DU, UK; NIHR Oxford Biomedical Research Centre, Second Floor, Unipart House Business Centre, Oxford OX4 2PG, UK.
Jones S; Oxford Radcliffe Biobank, Nuffield Department of Surgical Sciences, University of Oxford, Oxford OX3 9DU, UK.
Cerundolo V; Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
Sauka-Spengler T; Gene Regulatory Networks in Development and Disease Laboratory, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.
Yau C; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Centre for Computational Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK; Division of Informatics, Imaging and Data Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester M13 9PT, UK; Alan Turing Institute, London NW1 2DB, UK. Electronic address: .
Ahmed AA; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK. Electronic address: .
Pokaż więcej
Źródło :
Cancer cell [Cancer Cell] 2020 Feb 10; Vol. 37 (2), pp. 226-242.e7.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
MeSH Terms :
Epithelial Cells/*pathology
Fallopian Tube Neoplasms/*metabolism
Fallopian Tubes/*pathology
Ovarian Neoplasms/*pathology
Cystadenocarcinoma, Serous/genetics ; Cystadenocarcinoma, Serous/metabolism ; Cystadenocarcinoma, Serous/pathology ; Epithelium/metabolism ; Epithelium/pathology ; Fallopian Tube Neoplasms/genetics ; Fallopian Tube Neoplasms/pathology ; Fallopian Tubes/metabolism ; Female ; Gene Expression Regulation, Neoplastic/genetics ; Genetic Heterogeneity ; Humans ; Ovarian Neoplasms/metabolism
Czasopismo naukowe
Tytuł :
A 3-Tier Chemotherapy Response Score for Ovarian/Fallopian Tube/Peritoneal High-grade Serous Carcinoma: Is it Clinically Relevant?
Autorzy :
Lawson BC; Departments of Pathology.
Euscher ED; Departments of Pathology.
Bassett RL; Biostatistics.
Liu J; Departments of Pathology.
Ramalingam P; Departments of Pathology.
Zhong Y; Departments of Pathology.; Department of Pathology, The First Hospital of Jilin University, Changchun, Jilin Province, China.
Fleming ND; Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Malpica A; Departments of Pathology.
Pokaż więcej
Źródło :
The American journal of surgical pathology [Am J Surg Pathol] 2020 Feb; Vol. 44 (2), pp. 206-213.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
Journal Info :
Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7707904 Publication Model: Print Cited Medium: Internet ISSN: 1532-0979 (Electronic) Linking ISSN: 01475185 NLM ISO Abbreviation: Am. J. Surg. Pathol. Subsets: MEDLINE
MeSH Terms :
Clinical Decision Rules*
Neoadjuvant Therapy*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Cystadenocarcinoma, Serous/*drug therapy
Fallopian Tube Neoplasms/*drug therapy
Ovarian Neoplasms/*drug therapy
Peritoneal Neoplasms/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Chemotherapy, Adjuvant ; Cystadenocarcinoma, Serous/mortality ; Cystadenocarcinoma, Serous/pathology ; Cystadenocarcinoma, Serous/surgery ; Fallopian Tube Neoplasms/mortality ; Fallopian Tube Neoplasms/pathology ; Fallopian Tube Neoplasms/surgery ; Female ; Follow-Up Studies ; Humans ; Laparoscopy ; Middle Aged ; Neoplasm Grading ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/surgery ; Peritoneal Neoplasms/mortality ; Peritoneal Neoplasms/pathology ; Peritoneal Neoplasms/surgery ; Retrospective Studies ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer.
Autorzy :
Banys-Paluchowski M; Department of Gynecology and Obstetrics, Asklepios Klinik Barmbek, Rübenkamp 220, 22307, Hamburg, Germany.
Fehm T; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Neubauer H; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Paluchowski P; Department of Gynecology and Obstetrics, Regio Klinik Pinneberg, Fahltskamp 74, 25421, Pinneberg, Germany.
Krawczyk N; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Meier-Stiegen F; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Wallach C; Department of Gynecology and Obstetrics, Regio Klinik Pinneberg, Fahltskamp 74, 25421, Pinneberg, Germany.
Kaczerowsky A; Department of Gynecology and Obstetrics, Marienkrankenhaus Hamburg, Alfredstr. 9, 22087, Hamburg, Germany.
Gebauer G; Department of Gynecology and Obstetrics, Asklepios Klinik Barmbek, Rübenkamp 220, 22307, Hamburg, Germany. .
Pokaż więcej
Źródło :
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2020 Apr; Vol. 301 (4), pp. 1027-1035. Date of Electronic Publication: 2020 Mar 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8710213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0711 (Electronic) Linking ISSN: 09320067 NLM ISO Abbreviation: Arch. Gynecol. Obstet. Subsets: MEDLINE
MeSH Terms :
Biomarkers, Tumor/*blood
Fallopian Tube Neoplasms/*physiopathology
Neoplastic Cells, Circulating/*pathology
Ovarian Neoplasms/*physiopathology
Peritoneal Neoplasms/*physiopathology
Fallopian Tube Neoplasms/mortality ; Female ; Humans ; Ovarian Neoplasms/mortality ; Peritoneal Neoplasms/mortality ; Prognosis ; Prospective Studies ; Survival Analysis
Czasopismo naukowe
Tytuł :
Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study.
Autorzy :
Powell CB; Kaiser Permanente Northern California Gynecologic Cancer Program, San Francisco, CA, United States of America; Kaiser Permanente Division of Research, Oakland, CA, United States of America. Electronic address: .
Littell RD; Kaiser Permanente Northern California Gynecologic Cancer Program, San Francisco, CA, United States of America.
Landen CN Jr; Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA, United States of America.
Pramanik S; Santa Clara Valley Medical Center, San Jose, CA, United States of America.
Hamilton IC; Kaiser Permanente Division of Research, Oakland, CA, United States of America.
Suh-Burgmann EJ; Kaiser Permanente Division of Research, Oakland, CA, United States of America; Kaiser Permanente Northern California Gynecologic Oncology Program, Walnut Creek, CA, United States of America.
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2020 Mar; Vol. 156 (3), pp. 636-640. Date of Electronic Publication: 2020 Jan 07.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol. Oncol. Subsets: MEDLINE
MeSH Terms :
Catheterization/*instrumentation
Fallopian Tube Neoplasms/*pathology
Fallopian Tubes/*cytology
Hysteroscopy/*instrumentation
Catheterization/methods ; Cytodiagnosis/instrumentation ; Cytodiagnosis/methods ; Diagnosis, Differential ; Fallopian Tube Neoplasms/diagnosis ; Fallopian Tubes/pathology ; Feasibility Studies ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Germ-Line Mutation ; Humans ; Hysteroscopy/methods ; Middle Aged ; Neoplasm Staging ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/prevention & control ; Ovarian Neoplasms/surgery ; Pilot Projects ; Salpingo-oophorectomy
Czasopismo naukowe
Tytuł :
A Focus of Differentiated Myeloid Sarcoma in a Ligation Specimen of the Fallopian Tube: No Evidence of Hematologic Abnormality in 18 Years of Follow-up Despite Absence of Treatment.
Autorzy :
Castro E; Baylor Scott & White Medical Center, Temple, TX, USA.; Texas A&M University College of Medicine, Temple, TX, USA.
Morales L; Baylor Scott & White Medical Center, Temple, TX, USA.; Texas A&M University College of Medicine, Temple, TX, USA.
Zreik R; Baylor Scott & White Medical Center, Temple, TX, USA.; Texas A&M University College of Medicine, Temple, TX, USA.
Donner LR; Baylor Scott & White Medical Center, Temple, TX, USA.; Texas A&M University College of Medicine, Temple, TX, USA.
Pokaż więcej
Źródło :
International journal of surgical pathology [Int J Surg Pathol] 2020 Feb; Vol. 28 (1), pp. 99-101. Date of Electronic Publication: 2019 Jul 25.
Typ publikacji :
Case Reports; Journal Article
Journal Info :
Publisher: Sage Publications Country of Publication: United States NLM ID: 9314927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1940-2465 (Electronic) Linking ISSN: 10668969 NLM ISO Abbreviation: Int. J. Surg. Pathol. Subsets: MEDLINE
MeSH Terms :
Fallopian Tube Neoplasms/*pathology
Sarcoma, Myeloid/*pathology
Adult ; Fallopian Tube Neoplasms/diagnosis ; Female ; Humans ; Incidental Findings ; Sarcoma, Myeloid/diagnosis ; Sterilization, Tubal
Czasopismo naukowe
Tytuł :
Effect of Surgical Specialty on Management of Adnexal Masses in Children and Adolescents: An 8-Year Single-Center Review.
Autorzy :
Peeraully R; Department of Pediatric Urology, Nottingham Children's Hospital, Queens Medical Centre, Nottingham, United Kingdom.
Henderson K; Department of Pediatric Urology, Nottingham Children's Hospital, Queens Medical Centre, Nottingham, United Kingdom.
Fairbrother K; Department of Pediatric Urology, Nottingham Children's Hospital, Queens Medical Centre, Nottingham, United Kingdom.
Patel R; Department of Pediatric Urology, Nottingham Children's Hospital, Queens Medical Centre, Nottingham, United Kingdom.
Fraser N; Department of Pediatric Urology, Nottingham Children's Hospital, Queens Medical Centre, Nottingham, United Kingdom.
Shenoy M; Department of Pediatric Urology, Nottingham Children's Hospital, Queens Medical Centre, Nottingham, United Kingdom.
Williams A; Department of Pediatric Urology, Nottingham Children's Hospital, Queens Medical Centre, Nottingham, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
Journal of pediatric and adolescent gynecology [J Pediatr Adolesc Gynecol] 2020 Feb; Vol. 33 (1), pp. 89-92. Date of Electronic Publication: 2019 Jun 27.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Elsevier Science Country of Publication: United States NLM ID: 9610774 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4332 (Electronic) Linking ISSN: 10833188 NLM ISO Abbreviation: J Pediatr Adolesc Gynecol Subsets: MEDLINE
MeSH Terms :
Specialization*
Fallopian Tube Neoplasms/*surgery
Ovarian Cysts/*surgery
Ovarian Neoplasms/*surgery
Adolescent ; Child ; Cohort Studies ; Fallopian Tube Neoplasms/diagnostic imaging ; Female ; Fertility Preservation/methods ; Gynecology/methods ; Humans ; Laparoscopy/methods ; Organ Sparing Treatments/standards ; Ovarian Cysts/diagnostic imaging ; Ovarian Neoplasms/diagnostic imaging ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Incidence of germline BRCA1/2 mutations in women with tubo-ovarian high-grade serous carcinomas with and without serous tubal intra-epithelial carcinomas.
Autorzy :
Dowson CB; Genetic Services of Western Australia, King Edward Memorial Hospital for Women Perth, Subiaco, Western Australia, Australia .
Stewart C; Department of Histopathology, King Edward Memorial Hospital for Women Perth, Subiaco, Western Australia, Australia.
O'Sullivan S; Genetic Services of Western Australia, King Edward Memorial Hospital for Women Perth, Subiaco, Western Australia, Australia.; WOMEN Centre, West Leederville, Western Australia, Australia.
Pachter N; Genetic Services of Western Australia, King Edward Memorial Hospital for Women Perth, Subiaco, Western Australia, Australia.; School of Medicine, University of Western Australia Faculty of Medicine Dentistry and Health Sciences, Crawley, Western Australia, Australia.
Schofield L; Genetic Services of Western Australia, King Edward Memorial Hospital for Women Perth, Subiaco, Western Australia, Australia.
Cohen PA; Gynaecological Oncology, St John of God Hospital Bendat Family Comprehensive Cancer Centre, Perth, Western Australia, Australia.; Division of Obstetrics & Gynaecology; Health & Medical Sciences, University of Western Australia, Perth, Western Australia, Australia.
Pokaż więcej
Źródło :
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2020 Jan; Vol. 30 (1), pp. 94-99. Date of Electronic Publication: 2019 Nov 07.
Typ publikacji :
Journal Article
Journal Info :
Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int. J. Gynecol. Cancer Subsets: MEDLINE
MeSH Terms :
Germ-Line Mutation*
BRCA1 Protein/*genetics
BRCA2 Protein/*genetics
Cystadenocarcinoma, Serous/*genetics
Fallopian Tube Neoplasms/*genetics
Ovarian Neoplasms/*genetics
Adult ; Aged ; Cystadenocarcinoma, Serous/pathology ; Fallopian Tube Neoplasms/pathology ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Testing ; Humans ; Incidence ; Middle Aged ; Ovarian Neoplasms/pathology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study.
Autorzy :
O'Cearbhaill RE; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: .
Deng W; NRG Oncology Statistics & Data Management Center, Roswell Park Cancer Institute, Buffalo, NY, USA. Electronic address: .
Chen LM; University of California San Francisco, San Francisco, CA, USA. Electronic address: .
Lucci JA 3rd; The University of Texas Health Science Center at Houston, Houston, TX, USA. Electronic address: .
Behbakht K; Rush University Medical Center, Chicago, IL, USA. Electronic address: .
Spirtos NM; Women's Cancer Center of Nevada, Las Vegas, NV, USA. Electronic address: .
Muller CY; Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, Albuquerque, NM, USA. Electronic address: .
Benigno BB; University Gynecologic Oncology, Atlanta, GA, USA. Electronic address: .
Powell MA; Washington University School of Medicine, St. Louis, MO, USA. Electronic address: .
Berry E; Northwestern Medicine Prentice Women's Hospital, Chicago, IL, USA. Electronic address: https://dremilyberry.com.
Tewari KS; University of California Irvine Medical Center, Orange, CA, USA. Electronic address: .
Hanjani P; Hanjani Institute for Gynecologic Oncology, Abington Memorial Hospital, Abington, PA, USA. Electronic address: .
Lankes HA; NRG Oncology, Operations Center-Philadelphia East, Philadelphia PA and Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Electronic address: .
Aghajanian C; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: .
Sabbatini PJ; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2019 Dec; Vol. 155 (3), pp. 393-399. Date of Electronic Publication: 2019 Oct 22.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info :
Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol. Oncol. Subsets: MEDLINE
MeSH Terms :
Adjuvants, Immunologic/*administration & dosage
Cancer Vaccines/*administration & dosage
Carcinoma, Ovarian Epithelial/*therapy
Fallopian Tube Neoplasms/*therapy
Ovarian Neoplasms/*therapy
Peritoneal Neoplasms/*therapy
Vaccines, Conjugate/*administration & dosage
Adjuvants, Immunologic/adverse effects ; Adult ; Aged ; Aged, 80 and over ; Cancer Vaccines/adverse effects ; Cancer Vaccines/immunology ; Carcinoma, Ovarian Epithelial/immunology ; Carcinoma, Ovarian Epithelial/pathology ; Double-Blind Method ; Fallopian Tube Neoplasms/immunology ; Fallopian Tube Neoplasms/pathology ; Female ; Hemocyanins/administration & dosage ; Hemocyanins/immunology ; Humans ; Middle Aged ; Neoplasm Staging ; Ovarian Neoplasms/immunology ; Ovarian Neoplasms/pathology ; Peritoneal Neoplasms/immunology ; Peritoneal Neoplasms/pathology ; Vaccines, Conjugate/adverse effects ; Vaccines, Conjugate/immunology
Czasopismo naukowe
Tytuł :
Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women.
Autorzy :
Ida T; Department of Obstetrics and Gynecology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan. .
Fujiwara H; Department of Obstetrics and Gynecology, Jichi Medical University, Shimotsuke, Japan.
Kiriu T; Department of Pathology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Taniguchi Y; Department of Obstetrics and Gynecology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Kohyama A; Department of Obstetrics and Gynecology, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Pokaż więcej
Źródło :
Journal of gynecologic oncology [J Gynecol Oncol] 2019 Nov; Vol. 30 (6), pp. e96.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Asian Society of Gynecologic Oncology Country of Publication: Korea (South) NLM ID: 101483150 Publication Model: Print Cited Medium: Internet ISSN: 2005-0399 (Electronic) Linking ISSN: 20050380 NLM ISO Abbreviation: J Gynecol Oncol Subsets: MEDLINE
MeSH Terms :
Parity*
Cystadenocarcinoma, Serous/*pathology
Fallopian Tube Neoplasms/*pathology
Ovarian Neoplasms/*pathology
Tumor Suppressor Protein p53/*metabolism
Adult ; Aged ; Aged, 80 and over ; Cystadenocarcinoma, Serous/genetics ; Fallopian Tube Neoplasms/genetics ; Female ; Humans ; Middle Aged ; Neoplasm Grading ; Ovarian Neoplasms/genetics ; Pregnancy ; Prospective Studies ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies